In November 2021, SHIGERU AG has participated in Series A of Capretto ehf, a bio-venture at the University of Iceland.
Capretto ehf is an Icelandic based medical device company, building on research and development
work carried out at the University of Iceland, where Monocaprin and Monolaurin have been studied as antimicrobial lipids.
Comment